RYTM
Rhythm Pharmaceuticals Inc
$38.45
Earnings Summary
Revenue | $24.23Mn |
Net Profits | $-41.63Mn |
Net Profit Margins | -171.8% |
Highlights
Rhythm Pharmaceuticals Inc’s revenue jumped 175.7% since last year same period to $24.23Mn in the Q4 2023. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated 7.69% jump in its revenue since last 3-months.
Rhythm Pharmaceuticals Inc’s net profit jumped 2.91% since last year same period to $-41.63Mn in the Q4 2023. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated 5.73% jump in its net profits since last 3-months.
Rhythm Pharmaceuticals Inc’s net profit margin jumped 64.79% since last year same period to -171.8% in the Q4 2023. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated 12.46% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Rhythm Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter | -2.16 |
EPS Estimate Current Year | -2.16 |
Highlights
Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -2.16 - a -208.57% fall from last quarter’s estimates.
Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -2.16.
Key Ratios
Key ratios of the Rhythm Pharmaceuticals Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.7 |
Highlights
Rhythm Pharmaceuticals Inc’s earning per share (EPS) jumped 6.67% since last year same period to -0.7 in the Q4 2023. This indicates that the Rhythm Pharmaceuticals Inc has generated 6.67% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-08 | -0.74 | -0.76 | -2.7% |
2023-05-02 | -0.73 | -0.92 | -26.03% |
2024-02-29 | -0.7 | -0.7 | 0% |
2023-08-01 | -0.79 | -0.82 | -3.8% |
₹0 US Stocks a/c Opening Fee